<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39366747</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2399-9772</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>04</Day></PubDate></JournalIssue><Title>BMJ paediatrics open</Title><ISOAbbreviation>BMJ Paediatr Open</ISOAbbreviation></Journal><ArticleTitle>Utility of respiratory viral testing in the risk stratification of young febrile infants presenting to emergency care settings: a protocol for systematic review and meta-analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e002778</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjpo-2024-002778</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Febrile infants under 3 months of age are at risk of invasive bacterial infection (IBI). It is currently unclear if testing for respiratory viruses may have a role in IBI risk stratification. If found to be associated with the likelihood of IBI, respiratory viral point-of-care testing may improve patient and caregiver experience, reduce costs and enhance antimicrobial stewardship.</AbstractText><AbstractText Label="METHODS AND ANALYSIS" NlmCategory="METHODS">This is a study protocol for a systematic review and meta-analysis that aims to answer the following question: <i>In young febrile infants presenting to emergency care settings does a positive respiratory viral test for RSV, Influenza or SARS-CoV2 (relative to a negative test) add value to current risk stratification pathways for the exclusion of invasive bacterial infection, subsequently enabling safe de-escalation of investigation and treatment</i>?A search strategy will include MEDLINE, EMBASE, Web of Science, The Cochrane Library and grey literature. Abstracts and then full texts will be independently screened for selection. Data extraction and quality assessment will be completed by two independent authors.The primary objective is to analyse the ability of a positive respiratory viral test to identify the overall risk of IBI. The secondary objective is to perform a subgroup analysis to investigate how the risk stratification alters based on other variables including virus type, patient characteristics and the presence of an identified source of fever.Bivariate random-effects meta-analysis will be undertaken. Diagnostic odds ratios (OR), sensitivity, specificity and positive and negative likelihood ratios will be calculated. The degree of heterogeneity and publication bias will be investigated and presented.</AbstractText><AbstractText Label="ETHICS AND DISSEMINATION" NlmCategory="BACKGROUND">Ethical approval is not required. We will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines to disseminate the study results through publication and conference presentations.</AbstractText><AbstractText Label="PROSPERO REGISTRATION NUMBER" NlmCategory="UNASSIGNED">This protocol is registered in PROSPERO-ID number: CRD42023433716.</AbstractText><CopyrightInformation>© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>Jordan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-8873-7343</Identifier><AffiliationInfo><Affiliation>Cardiff and Vale University Health Board, Cardiff, UK jordan.evans@wales.nhs.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health and Care Research Wales, Cardiff, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norman-Bruce</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Queen's University Belfast, Belfast, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mills</LastName><ForeName>Clare</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Queen's University Belfast, Belfast, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Umana</LastName><ForeName>Etimbuk</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-0780-8614</Identifier><AffiliationInfo><Affiliation>Queen's University Belfast, Belfast, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roe</LastName><ForeName>Jennie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiff and Vale University Health Board, Cardiff, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiff University, Cardiff, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitchell</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Mathematical Sciences Research Centre, Queen's University Belfast, Belfast, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McFetridge</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-1372-1360</Identifier><AffiliationInfo><Affiliation>Mathematical Sciences Research Centre, Queen's University Belfast, Belfast, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waterfield</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Wellcome Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Paediatr Open</MedlineTA><NlmUniqueID>101715309</NlmUniqueID><ISSNLinking>2399-9772</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001424" MajorTopicYN="N">Bacterial Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005334" MajorTopicYN="Y">Fever</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015201" MajorTopicYN="N">Meta-Analysis as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067716" MajorTopicYN="N">Point-of-Care Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018357" MajorTopicYN="N">Respiratory Syncytial Virus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000078202" MajorTopicYN="N">Systematic Reviews as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Infant</Keyword><Keyword MajorTopicYN="N">Respiratory</Keyword><Keyword MajorTopicYN="N">Virology</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>6</Day><Hour>7</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>6</Day><Hour>7</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>21</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39366747</ArticleId><ArticleId IdType="pmc">PMC11481119</ArticleId><ArticleId IdType="doi">10.1136/bmjpo-2024-002778</ArticleId><ArticleId IdType="pii">10.1136/bmjpo-2024-002778</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kuppermann N, Dayan PS, Levine DA, et al. A Clinical Prediction Rule to Identify Febrile Infants 60 Days and Younger at Low Risk for Serious Bacterial Infections. JAMA Pediatr. 2019;173:342–51. doi: 10.1001/jamapediatrics.2018.5501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2018.5501</ArticleId><ArticleId IdType="pmc">PMC6450281</ArticleId><ArticleId IdType="pubmed">30776077</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez B, Mintegi S, Bressan S, et al. Validation of the “Step-by-Step” Approach in the Management of Young Febrile Infants. Pediatrics. 2016;138:e20154381. doi: 10.1542/peds.2015-4381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2015-4381</ArticleId><ArticleId IdType="pubmed">27382134</ArticleId></ArticleIdList></Reference><Reference><Citation>Waterfield T, Lyttle MD, Munday C, et al. Validating clinical practice guidelines for the management of febrile infants presenting to the emergency department in the UK and Ireland. Arch Dis Child. 2022;107:329–34. doi: 10.1136/archdischild-2021-322586.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2021-322586</ArticleId><ArticleId IdType="pubmed">34531196</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Bruel A, Haj-Hassan T, Thompson M, et al. Diagnostic value of clinical features at presentation to identify serious infection in children in developed countries: a systematic review. Lancet. 2010;375:834–45. doi: 10.1016/S0140-6736(09)62000-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)62000-6</ArticleId><ArticleId IdType="pubmed">20132979</ArticleId></ArticleIdList></Reference><Reference><Citation>Díaz MG, García RP, Gamero DB, et al. Lack of Accuracy of Biomarkers and Physical Examination to Detect Bacterial Infection in Febrile Infants. Pediatr Emerg Care. 2016;32:664–8. doi: 10.1097/PEC.0000000000000401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PEC.0000000000000401</ArticleId><ArticleId IdType="pubmed">25822238</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence  Sepsis: recognition, diagnosis and early management nice guideline (NG51) 2016. www.nice.org.uk/guidance/ng51 Available.</Citation><ArticleIdList><ArticleId IdType="pubmed">31891456</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence  Fever in under 5s: assessment and initial management. nice guideline (NG143) 2019. https://www.nice.org.uk/guidance/ng143 Available.</Citation><ArticleIdList><ArticleId IdType="pubmed">31891472</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantell RH, Roberts KB, Adams WG, et al. Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old. Pediatrics. 2021;148:e2021052228. doi: 10.1542/peds.2021-052228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2021-052228</ArticleId><ArticleId IdType="pubmed">34281996</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldman RD, Scolnik D, Chauvin-Kimoff L, et al. Practice variations in the treatment of febrile infants among pediatric emergency physicians. Pediatrics. 2009;124:439–45. doi: 10.1542/peds.2007-3736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2007-3736</ArticleId><ArticleId IdType="pubmed">19620201</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers AJ, Kuppermann N, Anders J, et al. Practice Variation in the Evaluation and Disposition of Febrile Infants ≤60 Days of Age. J Emerg Med. 2019;56:583–91. doi: 10.1016/j.jemermed.2019.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jemermed.2019.03.003</ArticleId><ArticleId IdType="pmc">PMC6589384</ArticleId><ArticleId IdType="pubmed">31014970</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JS, Byun YH, Lee JY, et al. Clinical utility of procalcitonin in febrile infants younger than 3 months of age visiting a pediatric emergency room: a retrospective single-center study. BMC Pediatr. 2021;21:109. doi: 10.1186/s12887-021-02568-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12887-021-02568-5</ArticleId><ArticleId IdType="pmc">PMC7931518</ArticleId><ArticleId IdType="pubmed">33663442</ArticleId></ArticleIdList></Reference><Reference><Citation>Rybak A, Aupiais C, Cotillon M, et al. Reassessing the Performance of the “Step-By-Step” Approach to Febrile Infants 90 Days of Age and Younger in the Context of the COVID-19 Pandemic: A Multicentric Retrospective Study. Pediatr Infect Dis J. 2022;41:e365–8. doi: 10.1097/INF.0000000000003614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003614</ArticleId><ArticleId IdType="pmc">PMC9359674</ArticleId><ArticleId IdType="pubmed">35703301</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenfield BW, Lowery BM, Starke HE, et al. Frequency of serious bacterial infections in young infants with and without viral respiratory infections. Am J Emerg Med. 2021;50:744–7. doi: 10.1016/j.ajem.2021.09.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2021.09.069</ArticleId><ArticleId IdType="pubmed">34879497</ArticleId></ArticleIdList></Reference><Reference><Citation>Horner C, Cunney R, Demirjian A. Paediatric Common Infections Pathways: Improving Antimicrobial Stewardship and Promoting Ambulation for Children Presenting with Common Infections to Hospitals in the UK and Ireland. JAC-Antimicrobial Resistance;</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8210287</ArticleId><ArticleId IdType="pubmed">34223103</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey M, Lyttle MD, Cathie K, et al. Point-of-care testing in Paediatric settings in the UK and Ireland: a cross-sectional study. BMC Emerg Med. 2022;22:6. doi: 10.1186/s12873-021-00556-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12873-021-00556-7</ArticleId><ArticleId IdType="pmc">PMC8753865</ArticleId><ArticleId IdType="pubmed">35016622</ArticleId></ArticleIdList></Reference><Reference><Citation>May L, Tran N, Ledeboer NA. Point-of-care COVID-19 testing in the emergency department: current status and future prospects. Expert Rev Mol Diagn. 2021;21:1333–40. doi: 10.1080/14737159.2021.2005582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737159.2021.2005582</ArticleId><ArticleId IdType="pmc">PMC8631689</ArticleId><ArticleId IdType="pubmed">34758686</ArticleId></ArticleIdList></Reference><Reference><Citation>Leigh S, Grant A, Murray N, et al. The cost of diagnostic uncertainty: a prospective economic analysis of febrile children attending an NHS emergency department. BMC Med. 2019;17:48. doi: 10.1186/s12916-019-1275-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-019-1275-z</ArticleId><ArticleId IdType="pmc">PMC6402102</ArticleId><ArticleId IdType="pubmed">30836976</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>